🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our multi-omic analysis of gastric cancer peritoneal metastases is now available on bioRxiv Raghav Sundar Ong Chin-Ann Johnny Sam Klempner Hanneke van Laarhoven Filippo Pietrantonio biorxiv.org/content/10.110…

Our new Lombardia survey on digital pathologica.it/article/view/1…

Online Now: The hallmarks of cancer immune evasion dlvr.it/TFFy1H

Starting second day of NIBIT Meeting at Teatro Politeama Garibaldi in Palermo

Antonio Rosato from University of Padova presented integrated phenotypical and genomic approaches to decipher the tumor-immune landscape

Summary of landmark nature tumor atlas studies by National Cancer Institute leaders, enablined by Cancer Moonshot. Many important findings such as multiple cells collectively seed CRC tumors overturning widely held view that such cancers arise from single epithelial cells nature.com/articles/d4158…

Thrilled to share our paper published in nature, where we uncover a new process of tumor initiation through a polyclonal-to-monoclonal transition at the @precancerous stage. So proud of my fantastic team (led by Zhaolian Lu ) and incredible collaborators! nature.com/articles/s4158…

A super review of engineered T cells for cancer (CAR T and TILs) jamanetwork.com/journals/jama/… JAMA Jennifer N. Brudno, MD Dr Marcela Maus Christian Hinrichs

New #JITC article: Natural lung-tropic TH9 cells: a sharp weapon for established lung metastases bit.ly/49qrK9r

Very cool abstract by ADJ lab CSI Singapore Anand D Jeyasekharan ATR inhibition with gemcitabine suppresses a BCL6-regulated transcriptional program, reversing dark zone signature in DLBCL ashpublications.org/blood/article/…

New #JITC article: Multiomics reveals tumor microenvironment remodeling in locally advanced gastric and gastroesophageal junction cancer following neoadjuvant immunotherapy and chemotherapy bit.ly/3DhULYG

I am incredibly honored and excited to receive this award, thank you so much to EACR The Mark Foundation for Cancer Research Fondazione Pezcoller for this opportunity!!

Congrats to the winner of the 2025 EACR-The Mark Foundation for Cancer Research-Pezcoller Rising Star Award 🌟 Marta Kovatcheva 🏅 from IFOM! Her project titled “Controlling epithelial cell plasticity during tissue regeneration using one-carbon metabolism (PLAST-1C REGEN)”. pezcoller.it/en/awards/%F0%…

#Oncologia Università degli Studi di Milano, #INGM e Boehringer Ingelheim insieme nello sviluppo di un #anticorpomonoclonale per l'immunoterapia dei tumori che non interferisce con altre funzioni del sistema immunitario. Continua a leggere su #lastatalenews 👉shorturl.at/W0DBl

#SpatialRNAEncyclopedia Patho-DBiT #SpatialTranscriptomics FFPE Spatial Co-mapping of RNA Expression Splicing editing SNV AND ncRNAs (miRNA lncRNA rRNA snRNA snoRNA & more)👹 in situ polyA tailing all RNAs 10 μm/px (near single cell)➡️ >2000 genes > 6000 UMIs/px Lymphoma

🚀 We're hiring! Join the Casola & Tripodo Labs at IFOM as a Bioinformatics Data Analyst! 🔬 RNA-seq, TCR genetics, spatial omics. 📍 Position Based in Catania, collaborating with IFOM wet labs in Milan. 🧬 PhD/MSc in bioinformatics required. To apply: [email protected]

🧬 The Chk1-Sp1-CD59 axis weakens rituximab ability to kill lymphoma cells by impairing Complement-dependent cytotoxicity. Targeting this pathway could enhance chemoimmunotherapy outcomes. CSI Singapore Anand D Jeyasekharan 🔬#Complement #Immunotherapy #DLBCL Link: doi.org/10.1101/2025.0…

Reasoning about molecular features of the metastatic stroma. jeccr.biomedcentral.com/articles/10.11…

👩‍🔬 Science in action—tune in! 🎧

🤩 We’re thrilled to attend #USCAP2025 March 22nd - 27th with the crew! 💡 Stop by booth 641 to see how Judith and PathChatᵀᴹ revolutionize AI model development and pathology workflows. 🦾 📧 Want to connect 1:1? Drop us a line at [email protected] to schedule a chat! We can’t